F

Faeth Therapeutics

Develops cancer therapies via metabolic data

Associate Director/Director - Regulatory Operations

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree in a life science, information science, or related field.
  • At least 8 years of regulatory operations experience in biotech, pharmaceutical, or CRO/vendor environments, including demonstrated ownership of submissions from planning through dispatch.
  • Deep, hands-on knowledge of electronic Common Technical Document (eCTD) structure, lifecycle management, and validation, with practical experience across the United States and at least one ex-US region.
  • Direct experience preparing and submitting Investigational New Drug applications (INDs) and/or Clinical Trial Applications (CTAs), including work with contract research organizations (CROs) or partners on clinical trial applications.
  • Working proficiency with electronic publishing tools, electronic gateways, and regional portals.
  • Demonstrated ownership or administration of a Regulatory Information Management System (RIMS) platform, including data integrity, reporting, and system release and user acceptance testing (UAT) activities.
  • Practical understanding of 21 CFR Part 11, EU Annex 11, International Council for Harmonisation (ICH) guidelines, GxP documentation standards, records retention, and archival requirements.
  • Vendor management experience, including scoping, oversight, quality management, and performance accountability.
  • Advanced document formatting and template skills using Microsoft Word and Adobe Acrobat, and the ability to diagnose technical publishing issues independently.
  • Clear and effective communication across functions and levels, with messaging tailored to the audience and key stakeholders kept informed.
  • Ability to build cross-functional relationships and work effectively with internal teams, external partners, and vendors to achieve shared goals.
  • Ability to proactively identify challenges and develop practical solutions without waiting for direction.
  • Curiosity and initiative in using artificial intelligence and emerging technologies to improve efficiency, streamline workflows, and enhance work quality.

Responsibilities

  • Lead end-to-end planning, compilation, publishing, validation, and dispatch of regulatory submissions, including INDs, CTAs, amendments, annual reports and Development Safety Update Reports (DSURs), briefing packages, meeting requests, orphan drug and expedited-pathway applications, and future Marketing Authorization Applications (MAAs), New Drug Applications (NDAs), and Biologics License Applications (BLAs).
  • Own submission-level project plans, including content collection timelines, document readiness tracking, publishing windows, quality control cycles, and dispatch dates; escalate risks early with options.
  • Apply working knowledge of regional requirements across jurisdictions, including FDA eCTD Module 1, EU Clinical Trials Regulation and Clinical Trials Information System (EU CTR/CTIS), UK Medicines and Healthcare products Regulatory Agency (MHRA), Health Canada, and Asia-Pacific/rest-of-world regions, and translate differences into actionable guidance for authors and study teams.
  • Manage electronic dispatch and gateway operations, including FDA Electronic Submissions Gateway (ESG/Gateway), WebTrader, Common European Submission Portal (CESP), CTIS, and regional portals; administer accounts and certificates, run test submissions, and troubleshoot failed transmissions.
  • Perform and oversee technical and publishing quality control, including hyperlinks, bookmarks, granularity, lifecycle operations, PDF rendering, validation criteria, and eCTD backbone integrity; resolve validation errors before dispatch.
  • Maintain submission readiness for evolving standards, including eCTD v4.0, structured content, and regional electronic application form requirements, and lead organizational preparedness work.
  • Serve as business owner and day-to-day administrator of the RIMS platform, including configuration requests, user access and training, controlled vocabularies, and document and record lifecycles.
  • Maintain the integrity and completeness of registration, submission, correspondence, and health-authority commitment data so the system serves as a trusted source for reporting and inspection.
  • Lead system enhancements, migrations, and releases, including requirements gathering and vendor coordination in line with 21 CFR Part 11, EU Annex 11, and internal computer system validation procedures.
  • Build and maintain dashboards, metrics, and trackers that give Regulatory, Clinical Development, and Program Management visibility into submission status, commitments, and cycle times.
  • Develop and maintain standard operating procedures, work instructions, style guides, templates, and document-formatting standards; train authors and study teams in their use.
  • Own the regulatory archive, including official submission-ready copies, health-authority correspondence and meeting minutes, approvals, and licensing documentation, with defined retention periods and retrieval procedures.
  • Ensure archival practices satisfy GxP requirements and are defensible in an FDA or EU inspection or partner audit; support inspection preparation, requests, and responses.
  • Establish and maintain reconciliation processes between the archive, RIMS, the electronic Trial Master File (eTMF), and CRO-held records so record ownership is unambiguous at study close-out.
  • Act as the primary regulatory operations point of contact for CROs supporting IND and CTA submissions; define deliverables and formats, align timelines, review incoming documents for submission readiness, and drive issue resolution.
  • Manage publishing and regulatory operations vendors, including scope of work, service-level agreements (SLAs), budgets and accruals, capacity planning, quality oversight, and performance reviews; hold vendors accountable to agreed quality and turnaround standards.
  • Coordinate with local affiliates, regulatory consultants, and legal representatives in ex-US markets to secure country-specific documents, including legalized or notarized documents, Good Manufacturing Practice (GMP) certificates, Investigator’s Brochure (IB) translations, and labeling, on the critical path.
  • Partner cross-functionally with Clinical Operations, Chemistry, Manufacturing and Controls (CMC), Nonclinical, Quality, Pharmacovigilance, and Medical Writing to secure submission content on schedule and to the required standard.
  • Continuously improve regulatory operations processes by identifying where automation, templates, or better upstream discipline can reduce cycle time and rework.
  • Provide regulatory operations input into program planning and submission strategy discussions, including feasibility, sequencing, and resourcing implications of proposed filing plans.
  • Contribute to regulatory intelligence monitoring for operational and electronic-standards changes, and advise leadership on impact and required action.
  • Mentor junior staff and contractors; as the function grows, take on direct people management.

Desired Qualifications

  • Oncology experience supporting regulatory operations for oncology programs, including operational demands of expedited pathways such as Fast Track, Breakthrough Therapy, Regenerative Medicine Advanced Therapy (RMAT), and PRIME; adaptive or basket/umbrella trial designs; frequent protocol amendments; and parallel multi-region CTA submissions. Familiarity with Project Orbis and oncology-specific data expectations is a plus.
  • Experience supporting or preparing a marketing application (NDA, BLA, or MAA) or a major amendment in a lead operational role.
  • RIM administration or configuration experience, and eCTD v4.0 readiness work.
  • Experience supporting health-authority inspections or partner audits.
  • Regulatory Affairs Certified (RAC) certification or equivalent.

About the Company

Faeth Therapeutics

Develops cancer therapies via metabolic data

Faeth Therapeutics develops cancer therapies that combine anti-cancer drugs with precision diets. It uses a proprietary MetabOS platform to study drug-nutrient interactions and guide metabolic optimization across all tumor types. The product works by pairing drugs with tailored diets or metabolism-focused drugs to boost efficacy and lower toxicity, thereby improving treatment outcomes. Unlike many competitors that focus only on drugs, Faeth integrates nutrition and metabolism to optimize therapy and reduce adverse effects. Its goal is to offer therapeutic programs that enhance drug performance through diet and metabolic support, while expanding access via clinical trials to advance safer, more effective cancer treatments.

Company size
11-50
Company stage
Late Stage VC
Total funding
$92M
Headquarters
San Francisco, CA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Faeth Therapeutics

See more jobs